Dr. Jeffrey I. Gordon
Director
Genome Sciences & Systems Biology
Agilent
Japan
Biography
Dr. Gordon is recognized internationally as a pioneer and leader of the Microbiome research field. His efforts, including the influential 2005 NHGRI white-paper entitled "Extending Our View of Self: the Human Gut Microbiome Initiative (HGMI)" lead to the creation of the NIH "Human Microbiome Project Roadmap for Medical Research" funding initiative in 2007. Dr. Gordon's research is focused on understanding the mutualistic interactions that occur between humans and the trillions of commensal microbes that colonize each person’s gastrointestinal tract. His research employs germ-free mice as model hosts as well as metagenomics, metabolomics, microbiology, biochemistry and nutritional sciences to study the composition of the human gut microbiome and their roles and consequences for human health and development. Of particular interest to him and his group are areas related to malnutrition, obesity as well as to neuro and immune modulation and development.
Research Interest
Dr. Gordon and his lab will use Agilent solutions-state-of-the-art gas and liquid chromatographs, mass spectrometers and analytical software-to tease apart the complex relationships that exist between the gut microbiome and the body's physiology. More specifically, they will use Agilent solutions to develop GC/MS, LC/MS and analytical workflows for the study of microbial metabolites produced by the human gut microbiome.